Designing modular, automated vial fill-finish lines that balance high-output demands with small-batch precision in an Annex 1 ...
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds ...
Upperton Pharma Solutions submits MHRA application for a new Annex 1–compliant sterile manufacturing facility, expanding clinical-scale CDMO capacity for biotech and pharma companies.
Servier, an independent international pharmaceutical group, is acquiring Day One Biopharmaceuticals for $21.50 per share in ...
New South San Francisco center showcases how cutting-edge cryo-electron microscopy is transforming and accelerating drug discovery.
Nicoya Lifesciences is launching FastHDX, a hydrogen-deuterium exchange mass spectrometry platform to measure protein ...
Coating Place Inc., a Wisconsin‑based CDMO, is marking its 50th anniversary with continued expansion efforts and new additions to its executive team.
Forma Life Sciences has launched as an independent, operator-owned contract development and manufacturing organization (CDMO) in the U.S. The new CDMO is focused on oral solid dosage formulation ...
The FDA has approved Johnson & Johnson’s TECVAYLI plus DARZALEX FASPRO for the treatment of adults with relapsed or refractory multiple myeloma.
This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...
SmartSkin Technologies has introduced SmartSkin Seal Assurance, a solution designed to give pharmaceutical manufacturers real-time visibility into seal tightness.
Aims to enhance Frontage's global lab service capabilities and strengthen its presence in China and the Asia-Pac region.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results